Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ecstasy (drug)
2. Hydrochloride, N-methyl-3,4-methylenedioxyamphetamine
3. Mdma
4. Methylenedioxymethamphetamine
5. N Methyl 3,4 Methylenedioxyamphetamine
6. N Methyl 3,4 Methylenedioxyamphetamine Hydrochloride
7. N-methyl-3,4-methylenedioxyamphetamine
8. N-methyl-3,4-methylenedioxyamphetamine Hydrochloride
1. 64057-70-1
2. Mdma Hcl
3. 92279-84-0
4. 3,4-methylenedioxymethamphetamine Hydrochloride
5. (+/-)-3,4-methylenedioxymethamphetamine Hydrochloride
6. Knb4e1k0av
7. Midomafetamine Hydrochloride
8. Dtxsid5048893
9. Nsc-168383
10. D,l-mdma.hcl
11. S(+)-3,4-methylenedioxymethamphetamine Hydrochloride
12. Metabolites (street)
13. Xtc Hydrochloride
14. (+/-)-mdma Hydrochloride
15. Mdma Hydrochloride (1.0mg/ml In Methanol)
16. Dl-mdma Hydrochloride
17. Ncgc00168266-02
18. Unii-knb4e1k0av
19. Dl-3,4-methylenedioxymethamphetamine
20. Nsc 168383
21. Methylenedioxymethamphetamine Hydrochloride
22. N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine Hydrochloride
23. 3,4-methylenedioxy-n,alpha-dimethyl-beta-phenylethylamine Hydrochloride
24. S(+)-3 4-mdma Hcl
25. S-(+)-mdma Hydrochloride
26. N-methyl-3,4-methylenedioxyamphetamine Hydrochloride
27. Schembl2414825
28. Mdma Hydrochloride [mi]
29. Chembl3189075
30. Dtxcid1028819
31. 1,3-benzodioxole-5-ethanamine, N,alpha-dimethyl-, Hydrochloride
32. 1-(1,3-benzodioxol-5-yl)-n-methylpropan-2-amine Hydrochloride
33. 1-(1,3-benzodioxol-5-yl)-n-methylpropan-2-amine;hydrochloride
34. Midomafetamine Hydrochloride (usan)
35. Tox21_112889
36. 1,3-benzodioxole-5-ethanamine, N,.alpha.-dimethyl-, Hydrochloride
37. Mfcd00079444
38. Nsc168383
39. Phenethylamine, N,alpha-dimethyl-3,4-methylenedioxy-, Hydrochloride
40. Akos024457389
41. 1, N,.alpha.-dimethyl-, Hydrochloride
42. Club Drugs For Sale With Tracking Number
43. Pd019496
44. Cas-64057-70-1
45. Db-215428
46. Mdma Hydrochloride [incb Green List]
47. Ns00076343
48. D12937
49. ?)-3,4-methylenedioxymethamphetamine Hydrochloride
50. D,l-mdma.hcl, 1mg/ml In Methanol (as Free Base)
51. Q22330487
52. 1-(benzo[d][1,3]dioxol-5-yl)-n-methylpropan-2-amine Hydrochloride
53. Rac-mdma Hcl (rac-3,4-methylenedioxymethamphetamine Hydrochloride)
54. 3,4-methylenedioxy-n,.alpha.-dimethyl-.beta.-phenylethylamine Hydrochloride
55. Phenethylamine, N,.alpha.-dimethyl-3,4-methylenedioxy-, Hydrochloride
| Molecular Weight | 229.70 g/mol |
|---|---|
| Molecular Formula | C11H16ClNO2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 30.5 |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 186 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Adrenergic Uptake Inhibitors
Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)
Hallucinogens
Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)
Serotonin Agents
Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons. (See all compounds classified as Serotonin Agents.)
Drugs in Development
Details:
The funding will be used for a pilot study examining 3,4-methylenedioxymethamphetamine (MDMA)-assisted massed exposure therapy for post-traumatic stress disorder.
Lead Product(s): 3,4-Methylenedioxymethamphetamine HCl,Inapplicable
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: MAPS
Deal Size: $0.2 million Upfront Cash: Undisclosed
Deal Type: Funding August 27, 2024
Lead Product(s) : 3,4-Methylenedioxymethamphetamine HCl,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : MAPS
Deal Size : $0.2 million
Deal Type : Funding
MAPS Awards Grant for Pilot MDMA-assisted Massed Exposure Therapy Trial
Details : The funding will be used for a pilot study examining 3,4-methylenedioxymethamphetamine (MDMA)-assisted massed exposure therapy for post-traumatic stress disorder.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
August 27, 2024
Details:
3,4-Methylenedioxymethamphetamine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Stress Disorders, Post-Traumatic.
Lead Product(s): 3,4-Methylenedioxymethamphetamine HCl,Inapplicable
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 15, 2013
Lead Product(s) : 3,4-Methylenedioxymethamphetamine HCl,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
Details : 3,4-Methylenedioxymethamphetamine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Stress Disorders, Post-Traumatic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 15, 2013
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
49
PharmaCompass offers a list of 3,4-Methylenedioxymethamphetamine HCl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right 3,4-Methylenedioxymethamphetamine HCl manufacturer or 3,4-Methylenedioxymethamphetamine HCl supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 3,4-Methylenedioxymethamphetamine HCl manufacturer or 3,4-Methylenedioxymethamphetamine HCl supplier.
A midomafetamine hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of midomafetamine hydrochloride, including repackagers and relabelers. The FDA regulates midomafetamine hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. midomafetamine hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A midomafetamine hydrochloride supplier is an individual or a company that provides midomafetamine hydrochloride active pharmaceutical ingredient (API) or midomafetamine hydrochloride finished formulations upon request. The midomafetamine hydrochloride suppliers may include midomafetamine hydrochloride API manufacturers, exporters, distributors and traders.
midomafetamine hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of midomafetamine hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right midomafetamine hydrochloride GMP manufacturer or midomafetamine hydrochloride GMP API supplier for your needs.
A midomafetamine hydrochloride CoA (Certificate of Analysis) is a formal document that attests to midomafetamine hydrochloride's compliance with midomafetamine hydrochloride specifications and serves as a tool for batch-level quality control.
midomafetamine hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each midomafetamine hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
midomafetamine hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (midomafetamine hydrochloride EP), midomafetamine hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (midomafetamine hydrochloride USP).
